ããã«ãã£ã¹ AG ã¯ãäžçäžã§ãã«ã¹ã±ã¢è£œåã®ç ç©¶ãéçºã補é ã販売ãè¡ã£ãŠããŸããå瀟ã¯ã驿°çå»è¬åãšãµã³ãã® 2 ã€ã®ã»ã°ã¡ã³ãã§äºæ¥ãå±éããŠããŸãã驿°çå»è¬åã»ã°ã¡ã³ãã§ã¯ãæ£è
ãšå»çæäŸè
åãã®åŠæ¹è¬ãæäŸããŠããŸãããŸããçŒç§ãç¥çµç§åŠãå
ç«åŠãèèç
åŠããã³ç®èç§ãåŒåžåšãæ¢åè¬ãå¿è¡ç®¡ãè
èããã³ä»£è¬è¬ãæäŸããŠããŸãããµã³ãã»ã°ã¡ã³ãã§ã¯ãããŸããŸãªæ²»çé åã«ããã£ãŠäœååå»è¬åã®æå¹æåãšå®æå€åœ¢ã第äžè
ã«æäŸããŠããã»ãã宿å€åœ¢ã®æææè¬ãæäŸããŠããŸãããŸããäž»ã«æçç©è³ªãªã©ã®å»è¬åæå¹æåããã³äžéäœããã€ãªã·ãã©ãŒãªã©ã®ã¿ã³ãã¯è³ªãŸãã¯ãã®ä»ã®ãã€ãªãã¯ãããžãŒããŒã¹ã®è£œåãããã³ãã€ãªãã¯ãããžãŒè£œé ãµãŒãã¹ãæäŸããŠããŸããããã«ãã£ã¹ AG ã¯ãã€ã³ã¯ãªã·ã©ã³ã®éçºã補é ãåååã«é¢ã㊠Alnylam Pharmaceuticals ãšã©ã€ã»ã³ã¹ããã³ååå¥çŽãçµãã§ããŸããŸããKura Oncology, Inc. ãšèšåºææºããé é žéšæå¹³äžç®ããæ£è
ã察象ã«ããã£ããã¡ã«ãããšã¢ã«ããªã·ãã®äœµçšãè©äŸ¡ããŠããŸããå瀟㯠1996 幎ã«èšç«ãããã¹ã€ã¹ã®ããŒãŒã«ã«æ¬ç€Ÿã眮ããŠããŸãã